Cortical event-related potentials in preclinical familial Alzheimer disease

Neurology

Volumn 73, Issue 20, 2009, Pages 1649-1655

  Golob, E J ^a   Ringman, J M ^b,c   Irimajiri, R ^a   Bright, S ^a   Schaffer, B ^c   Medina, L D ^b,c   Starr, A ^a  

^a Tulane University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUDITORY DISCRIMINATION; BEHAVIORAL SCIENCE; BRAIN CORTEX; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; LATENT PERIOD; MALE; PRIORITY JOURNAL; RATING SCALE;

EID: 73449119246     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181c1de77     Document Type: Article

References (35)

1. Rossor M, Fox NC, Beck J, Campbell TC, Collinge J. Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 1996;347:1560.
2. Fox NC, Kennedy AM, Harvey RJ, et al. Clinicopatholog-ical features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene: pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 1997;120:491-501.
3. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778.
4. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor pro-tein gene with familial Alzheimer's disease. Nature 1991; 349:704-706.
5. Lampe TH, Bird TD, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994;36:368-378.
6. Lleo A, Berezovska O, Growdon JH, Hyman BT. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am J Geriatr Psychiatry 2004;12:146-156.
7. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-116.
8. Golob EJ, Irimajiri R, Starr A. Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. Brain 2007;130:740-752.
9. Golob EJ, Starr A. Effects of stimulus sequence on event-related potentials and reaction time during target detection in Alzheimer's disease. Clin Neurophysiol 2000;111: 1438-1449.
10. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psy-chogeriatr 1994;6:45-58; discussion 62.
11. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997;9:173-176.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13. Polich J. P300 clinical utility and control of variability. J Clin Neurophysiol 1998;15:14-33.
14. Gratton G, Coles MG, Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 1983;55:468-484.
15. Nunez PL, Srinivasan R. Electric Fields of the Brain: The Neurophysics of EEG, 2nd ed. New York, NY: Oxford University Press; 2006.
16. Goodin DS, Squires KC, Starr A. Long latency event-related components of the auditory evoked potential in dementia. Brain 1978;101:635-648.
17. Duncan CC, Kosmidis MH, Mirsky AF. Closed head injury-related information processing deficits: an event-related potential analysis. Int J Psychophysiol 2005;58: 133-157.
18. Newton MR, Barrett G, Callanan MM, Towell AD. Cognitive event-related potentials in multiple sclerosis. Brain 1989;112:1637-1660.
19. Patterson JV, Michalewski HJ, Starr A. Latency variability of the components of auditory event-related potentials to infrequent stimuli in aging, Alzheimer-type dementia, and depression. Electroencephalogr Clin Neurophysiol 1988; 71:450-460.
20. Bennys K, Portet F, Touchon J, Rondouin G. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. J Clin Neurophysiol 2007;24:405-412.
21. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007;118:2128-2148.
22. Starr A, Golob EJ. Cognitive factors modulating auditory cortical potentials. In: Burkard R, Don M, Eggermont JJ, eds. Auditory Evoked Potentials: Basic Principles and Clinical Application. Philadelphia: Lippincott Williams & Wilkins; 2006:508-525.
23. Crowley KE, Colrain IM. A review of the evidence for P2 being an independent component process: age, sleep and modality. Clin Neurophysiol 2004;115:732-744.
24. Reite M, Teale P, Zimmerman J, Davis K, Whalen J. Source location of a 50 msec latency auditory evoked field component. Electroencephalogr Clin Neurophysiol 1988;70:490-498.
25. Liegeois-Chauvel C, Musolino A, Badier JM, Marquis P, Chauvel P. Evoked potentials recorded from the auditory cortex in man: evaluation and topography of the middle latency components. Electroencephalogr Clin Neuro-physiol 1994;92:204-214.
26. Halgren E, Marinkovic K, Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol 1998;106: 156-164.
27. Rossini PM, Buscema M, Capriotti M, et al. Is it possible to automatically distinguish resting EEG data of normal elderly vs. mild cognitive impairment subjects with high degree of accuracy? Clin Neurophysiol 2008;119:1534-1545.
28. Schott JM, Fox NC, Frost C, et al. Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 2003;53:181-188.
29. Kennedy AM, Frackowiak RS, Newman SK, et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995;186:17-20.
30. Ringman JM, O'Neill J, Geschwind D, et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 2007;130: 1767-1776.
31. Golob EJ, Johnson JK, Starr A. Auditory event-related potentials during target detection are abnormal in mild cognitive impairment. Clin Neurophysiol 2002;113: 151-161.
32. Frodl T, Hampel H, Juckel G, et al. Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's disease. Psychophysiology 2002;39:175-181.
33. Irimajiri R, Golob EJ, Starr A. Auditory brainstem, middle-and long-latency evoked potentials in mild cognitive impairment. Clin Electroencephalogr 2005;116: 1918-1929.
34. Irimajiri R, Golob EJ, Starr A. ApoE genotype and auditory cortical sensory and cognitive potentials in healthy older females. Neurobiol Aging (in press 2009).
35. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.